Submitted by Anonymous (not verified) on 4 December 2023 - 13:54
Human medicines European public assessment report (EPAR): Hycamtin, topotecan, Ovarian Neoplasms;Uterine Cervical Neoplasms;Small Cell Lung Carcinoma, Date of authorisation: 12/11/1996, Revision: 39, Status: Authorised
Source: